These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4028283)

  • 1. A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections.
    Mangini P; Cicchetti M; Bottaro L; Messina V; Brancadoro MT; Puppo F
    Chemioterapia; 1985 Jun; 4(3):222-6. PubMed ID: 4028283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Update on antibiotic therapy. 17) A combination of fosfomycin and cephalexin (cefemic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 May; 74(20):1217-22. PubMed ID: 6379514
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of cofosfolactamine in localized bacterial infections].
    Scalzini A; Chiodera A; Sueri L
    G Ital Chemioter; 1984; 31(1-2):205-6. PubMed ID: 6468828
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial.
    Novelli A; Rizzo M; Buzzoni P; Coronnello M; Alunno Pergentini S; Giganti E; Periti P
    Chemioterapia; 1984 Oct; 3(5):281-5. PubMed ID: 6398125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials.
    Falagas ME; Vouloumanou EK; Togias AG; Karadima M; Kapaskelis AM; Rafailidis PI; Athanasiou S
    J Antimicrob Chemother; 2010 Sep; 65(9):1862-77. PubMed ID: 20587612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of systemic prophylaxis with metronidazole/placebo and metronidazole/fosfomycin in colorectal surgery. A clinical study demonstrating the need for additional anti-aerobic prophylactic cover.
    Lindhagen J; Andåker L; Höjer H
    Acta Chir Scand; 1984; 150(4):317-23. PubMed ID: 6377784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.
    Roussos N; Karageorgopoulos DE; Samonis G; Falagas ME
    Int J Antimicrob Agents; 2009 Dec; 34(6):506-15. PubMed ID: 19828298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with fosfomycin in urinary tract infections (author's transl)].
    Peters HJ; Eicher R
    MMW Munch Med Wochenschr; 1981 May; 123(18):748-50. PubMed ID: 6785627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update on antibiotic therapy. 15) A combination of fosfomycin and amoxicillin (penamic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 Mar; 74(13):769-74. PubMed ID: 6835564
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection.
    Stein GE
    Clin Ther; 1999 Nov; 21(11):1864-72. PubMed ID: 10890258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fosfomycin in severe infection in neonatology].
    Rossignol S; Regnier C
    Ann Pediatr (Paris); 1984 May; 31(5):437-44. PubMed ID: 6742722
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fosfomycin in the treatment of some infectious diseases].
    Aceti A; Vullo V; Ferone U; Delia S
    Clin Ter; 1979 Jan; 88(1):61-6. PubMed ID: 436378
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Mirakhur A; Gallagher MJ; Ledson MJ; Hart CA; Walshaw MJ
    J Cyst Fibros; 2003 Mar; 2(1):19-24. PubMed ID: 15463841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experiments in the use of fosfomycin in oral microbial infections].
    Quaranta M
    Dent Cadmos; 1983 Mar; 51(3):57-64. PubMed ID: 6576933
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study and use of fosfomycin in the clinical field].
    Azzaroli P; de Martinis E; Zoli F; Garoia C
    G Ital Chemioter; 1978; 25(1):1-4. PubMed ID: 376386
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of fosfomycin in antibiotic therapy. Its effectiveness in patients with acute renal insufficiency or on hemodialysis treatment].
    Rossi R; Colantonio G; Fraticelli M; Giura C; Quarenghi MI; Polli O; Ferradini MA; Nonini MO
    G Ital Chemioter; 1979; 26(1-2):315-7. PubMed ID: 554823
    [No Abstract]   [Full Text] [Related]  

  • 20. A comprehensive study of cefadroxil and cephalexin in the treatment of soft tissue infections.
    Ballantyne F
    J Int Med Res; 1980; 8(Suppl 1):70-4. PubMed ID: 7439509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.